The protein drug OPT-302, invented at the University of Helsinki, is approaching a crossroads where it will either succeed or fail.

Aging and regeneration are two of the most fascinating areas of life science.

When bigger competitors swallow innovative small companies or brands, the product quality can sometimes suffer due to attempts to increase productivity.